News | April 06, 2009

Lantheus Acquires Rights to MRA Contrast Agent for Peripheral Vascular Imaging

April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (formerly marketed as VASOVIST, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals.

In December 2008, EPIX received FDA marketing approval for the magnetic resonance angiography (MRA) agent MS-325 to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease. Currently, there are no other imaging agents approved for MRA in the U.S.

Under the terms of the agreement, Lantheus acquired the U.S. (including Puerto Rico), Canadian, and Australian rights to MS-325 from EPIX. EPIX will continue to own European and other ex-U.S. rights for the imaging agent. Lantheus is planning to launch MS-325 under a different name before the year-end.

MS-325 is an injectable intravascular contrast agent designed to provide improved imaging of the vascular system through MRA. MS-325 has been approved for marketing in the U.S. and in 37 countries outside the U.S.

For more information: www.lantheus.com.

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
X-ray of a knee replacement. CMS may change reimbursements for joint and knee replacements. Patient Marilyn Fornell.

CMS may change how it reimburses for knee replacements and said it may eliminate bundled payments for acute cardiac care.

Feature | Business | August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
CMS considers eliminating or changing bundled payments for orthopedic and knee replacement imaging. Photo by Vital Images

CMS is considering elimination or changing bundled payments for knee replacements. 

News | August 14, 2017 | Dave Fornell
...
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | Advanced Visualization | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Sponsored Content | Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Leslee Shaw, Ph.D., director of clinical research and professor of medicine at Emory University, Atlanta, and past-pr
Low Doses of Radiation Could Harm Cardiovascular Health
News | Radiation Dose Management | July 17, 2017
Ionizing radiation, such as X-rays, has a harmful effect on the cardiovascular system even at doses equivalent to...
Overlay Init